NAVELBINE 10MG-ML I-V VIAL 10 mg/ml Solution for injection 5ml Vial

Product Overview

Navelbine 10 mg/ml Solution for Injection is a potent chemotherapeutic agent containing Vinorelbine, developed by Pierre Fabre. It is specifically formulated for intravenous administration to treat certain types of cancer. As a prescription-only medicine, Navelbine is used under strict medical supervision as part of a comprehensive cancer treatment regimen.

This medication is crucial in the fight against various malignancies, working by interfering with the growth of cancer cells.

Benefits of Use

• Targeted therapy for specific cancer types, including non-small cell lung cancer and certain forms of breast cancer.
• Acts as an antineoplastic agent by disrupting microtubule dynamics, inhibiting cell division in rapidly growing cancer cells.
• Administered by healthcare professionals, ensuring precise dosing and controlled delivery.

How to Use

Navelbine 10 mg/ml Solution for Injection must be administered by a qualified healthcare professional. The following steps outline the general administration protocol:

1. The exact dosage and administration schedule will be determined by your doctor based on your specific condition, weight, and overall health.
2. Navelbine is administered as a slow intravenous injection or infusion, typically into a large vein, over several minutes.
3. It is crucial that the medication is administered correctly to avoid extravasation (leakage from the vein into surrounding tissue).
4. Blood tests will be conducted regularly before and during treatment to monitor blood counts and liver function.

Caution & Warnings

• Professional Administration: Navelbine must only be administered by a physician experienced in chemotherapy administration in a clinical setting.
• Myelosuppression: This medication can cause severe bone marrow suppression, leading to a significant decrease in white blood cells (increasing infection risk), red blood cells (anemia), and platelets (bleeding risk). Regular blood count monitoring is essential.
• Extravasation Risk: Care must be taken during administration to prevent leakage of the solution outside the vein, which can cause severe tissue damage.
• Pregnancy and Breastfeeding: Navelbine is contraindicated during pregnancy and breastfeeding due to potential harm to the fetus or infant. Effective contraception is required for patients of childbearing potential during and after treatment.
• Liver and Kidney Impairment: Dose adjustments may be necessary in patients with impaired liver or kidney function.
• Drug Interactions: Inform your doctor about all medications you are taking, including over-the-counter drugs, supplements, and herbal products, as Navelbine can interact with numerous other drugs.
• Neurological Effects: Peripheral neuropathy can occur, manifesting as numbness, tingling, or weakness in the extremities.

Ingredients

• Active Ingredient: Vinorelbine tartrate, equivalent to 10 mg of Vinorelbine base per ml.
• Excipient: Water for injections.

Product Details

• Strength: 10 mg/ml
• Form: Solution for injection
• Package Size: 5 ml Vial
• Manufacturer: Pierre Fabre Medicament
• Drug Type: Prescription Only Medicine (POM)
• Storage: Store unopened vials in a refrigerator (2°C - 8°C). Do not freeze. Keep the vial in the outer carton to protect from light.
• Shelf Life: 36 months (unopened vial) when stored under recommended conditions.